Trending Now
Business
Michael Jordan Sides With LeBron In Trump Tete-A-Tete
Michael Rapaport pressed Michael Jordan to check President Trump in his tete-a-tete with LeBron James and CNN's Don Lemon. Jordan must have heard him...
Claire McCaskill Thwarts Allergan’s Patent Transfer, Inflaming The Mohawks
The tete-a-tete between Allergan (AGN) and lawmakers over its patent sale to St. Regis Mohawks continues. Thursday Senator Claire McCaskill drafted a bill disallowing...
Lifestyle today
Entertainment
Launching Generic Vasopressin On Appeal Could Bankrupt Eagle Pharma
Eagle Pharma (EGRX) is an integrated pharmaceutical company that works with collaborators to help patients address unmet needs. The company is capable...
Stick A Fork In Allergan
Allergan (AGN) is one of the most talked about names in the pharmaceutical industry. The company, along with names like Bausch Health (NYSE:BHC) and...
Trump And The GE: Was Charlottesville A False Flag Or Tipping Point?
Trump And The Global Economy (“Trump And The GE”) had its fifth installment earlier this month. The event featured Missouri State Representative Maria Chappelle-Nadal...
Endo, Blaise Coleman Hunt For Acquisitions
Endo International (ENDP) remains one of the market's most frustrating, confounding stocks. The stock hit a high of over $18 in the second half...
Will GE Fob Off Its Industrial Gas Engine Problem?
Per Reuters General Electric (GE) is exploring the sale of its industrial gas engine business:
General Electric Co (GE.N) is exploring a sale of its...
Are Fed Presidents Pushing Powell To Prevent An Inverted Yield Curve?
The U.S. economy appears to be on solid footing. Unemployment is below 5% (considered full employment) and second quarter GDP growth is expected to...
This Is The ‘Pain Ahead’ Shock Exchange Predicted
The kids of the New York Shock Exchange predicted the Great Recession of 2008, yet the New York Times, Financial Times and have all...
Snap Is Burning Cash Like A Drunken Sailor
A few months ago Citron Research started coverage of Snap (SNAP) with a $17 price target. The stock shot up in the mid-single-digits on...






















































































































